A Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's
A Multi-center, Randomized Controlled Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers
Sponsor: Compedica Inc
Listed as NCT05193929, this NA trial focuses on Diabetic Foot Ulcer and remains ongoing. Sponsored by Compedica Inc, it has been updated 12 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Mar 2026 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Mar 2025 — Mar 2026 [monthly]
Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Feb 2023 — Mar 2024 [monthly]
Recruiting NA
-
Dec 2022 — Feb 2023 [monthly]
Recruiting NA
-
Sep 2022 — Dec 2022 [monthly]
Recruiting NA
-
Jul 2022 — Sep 2022 [monthly]
Recruiting NA
-
Jun 2022 — Jul 2022 [monthly]
Recruiting NA
-
May 2022 — Jun 2022 [monthly]
Recruiting NA
-
Feb 2022 — May 2022 [monthly]
Recruiting NA
First recorded
Dec 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Compedica Inc
- Professional Education and Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .